Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 266-411-4 | CAS number: 66576-71-4
Toxicological information
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- DNEL derivation method:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- DNEL derivation method:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- DNEL derivation method:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- DNEL derivation method:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- DNEL derivation method:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- DNEL derivation method:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- Dose descriptor starting point:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- DNEL derivation method:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- DNEL derivation method:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
- Modified dose descriptor starting point:
- other:
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- DNEL derivation method:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- DNEL derivation method:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- DNEL derivation method:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- Dose descriptor starting point:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- DNEL derivation method:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- Dose descriptor starting point:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- DNEL derivation method:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- Dose descriptor starting point:
- other: A review of this human health hazard endpoint for IMB against the CLP classification criteria confirmed there is no requirement for DNEL entry as no risk assessment is required for this human health endpoint.
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
